Science Translational Medicine (STM)
Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine. Despite 50 years of progress in our fundamental understanding of human biology and the emergence of powerful new technologies, the translation of this knowledge into effective new treatments and health measures has been slow. Science Translational Medicine seeks to publish articles that fill the scientific knowledge gaps at the junction of preclinical research and medical applications in order to accelerate the translation of this knowledge into new ways for preventing, diagnosing and treating human disease.
Berlin Institute of Health (BIH)
The mission of the Berlin Institute of Health (BIH) is medical translation: transferring biomedical research findings into novel approaches to personalized prediction, prevention, diagnostics and therapy and, conversely, using clinical observations to develop new research ideas. The aim is to deliver relevant medical benefits to patients and the population at large. The BIH is also committed to establishing a comprehensive translational ecosystem as translational research area at the Charité – one that places emphasis on a system-wide understanding of health and disease and that promotes change in the biomedical research culture. The BIH is funded 90 percent by the Federal Ministry of Education and Research (BMBF) and 10 percent by the State of Berlin. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), were independent member entities within the BIH until 2020. As of 2021, the BIH has been integrated into the Charité as the so-called third pillar; the MDC is privileged partner of the BIH.
BIH Center for Regenerative Therapies (BCRT)
Regenerative medicine – this is our passion. The BCRT was established as an interdisciplinary translational center with the goal of enhancing endogenous regeneration by cells, biomaterials, and factors which can be used to develop and implement innovative therapies and products. The primary focus of the BCRT is on diseases of the immune system, the musculoskeletal system, the cardiovascular system and in the field of tissue homeostasis and cachexia. At the BCRT clinicians and researchers are working closely together on the medicine of the future: Targeted, personalized medicine that depends on the early recognition of patients' individual healing potential.
German Research Foundation - Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is the central, independent research funding organisation in Germany. It serves all branches of science and the humanities by funding research projects at universities and other research institutions. The DFG promotes excellence by selecting the best research projects on a competitive basis and facilitating national and international collaboration among researchers. Its mandate also includes encouraging the advancement and training of early career researchers, promoting gender equality in the German scientific and academic communities, providing scientific policy advice, and fostering relations between the research community and society and the private sector.
The DFG is an association under private law. Its member organisations include research universities, non-university research institutions, such as the Max Planck Society, Fraunhofer, the Helmholtz Association and the Leibniz Association, the academies of sciences and humanities, and a number of scientific associations. The DFG has a current annual budget of € 3.3 billion, provided primarily by the German federal government (69 percent) and the states (29 percent), but also including EU funds and private donations.